Antibody specifically binding to IGF1R and application thereof

The invention belongs to the technical field of biological immunity, and particularly relates to an antibody specifically bound with IGF1R or an antigen binding fragment thereof, in particular to a fully human anti-IGF1R monoclonal antibody and application thereof. The present application also relat...

Full description

Saved in:
Bibliographic Details
Main Authors LIU SHUANG, WANG TAO, LIU YANSHUANG, XIE HONGMEI, LIANG YANGQIU, JI ZHONGSHENG, JIN LEI
Format Patent
LanguageChinese
English
Published 19.01.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The invention belongs to the technical field of biological immunity, and particularly relates to an antibody specifically bound with IGF1R or an antigen binding fragment thereof, in particular to a fully human anti-IGF1R monoclonal antibody and application thereof. The present application also relates to bispecific or multispecific molecules, immunoconjugates, pharmaceutical compositions, kits comprising the antibodies or antigen binding fragments thereof, and uses thereof. 本申请属于生物免疫技术领域,具体涉及特异性结合IGF1R的抗体或其抗原结合片段,尤其涉及全人源抗IGF1R单克隆抗体及其应用。本申请还涉及包含所述抗体或其抗原结合片段的双特异性或多特异性分子,免疫缀合物,药物组合物,试剂盒以及它们的用途。
AbstractList The invention belongs to the technical field of biological immunity, and particularly relates to an antibody specifically bound with IGF1R or an antigen binding fragment thereof, in particular to a fully human anti-IGF1R monoclonal antibody and application thereof. The present application also relates to bispecific or multispecific molecules, immunoconjugates, pharmaceutical compositions, kits comprising the antibodies or antigen binding fragments thereof, and uses thereof. 本申请属于生物免疫技术领域,具体涉及特异性结合IGF1R的抗体或其抗原结合片段,尤其涉及全人源抗IGF1R单克隆抗体及其应用。本申请还涉及包含所述抗体或其抗原结合片段的双特异性或多特异性分子,免疫缀合物,药物组合物,试剂盒以及它们的用途。
Author LIU YANSHUANG
JIN LEI
XIE HONGMEI
WANG TAO
LIANG YANGQIU
JI ZHONGSHENG
LIU SHUANG
Author_xml – fullname: LIU SHUANG
– fullname: WANG TAO
– fullname: LIU YANSHUANG
– fullname: XIE HONGMEI
– fullname: LIANG YANGQIU
– fullname: JI ZHONGSHENG
– fullname: JIN LEI
BookMark eNrjYmDJy89L5WSwc8wryUzKT6lUKC5ITc5My0xOzMmpVEjKzEvJzEtXKMlX8HR3MwxSSMxLUUgsKMgBypdk5ucplGSkFqXmp_EwsKYl5hSn8kJpbgZFN9cQZw_d1IL8-NTigsTk1LzUknhnP0NDcxMgMjF3NCZGDQAsdzHI
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
Physics
DocumentTitleAlternate 特异性结合IGF1R的抗体及其应用
ExternalDocumentID CN117417447A
GroupedDBID EVB
ID FETCH-epo_espacenet_CN117417447A3
IEDL.DBID EVB
IngestDate Fri Jul 19 13:06:00 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Chinese
English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CN117417447A3
Notes Application Number: CN202310858012
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240119&DB=EPODOC&CC=CN&NR=117417447A
ParticipantIDs epo_espacenet_CN117417447A
PublicationCentury 2000
PublicationDate 20240119
PublicationDateYYYYMMDD 2024-01-19
PublicationDate_xml – month: 01
  year: 2024
  text: 20240119
  day: 19
PublicationDecade 2020
PublicationYear 2024
RelatedCompanies CHANGCHUN GENESCIENCE PHARMACEUTICALS CO., LTD
RelatedCompanies_xml – name: CHANGCHUN GENESCIENCE PHARMACEUTICALS CO., LTD
Score 3.653624
Snippet The invention belongs to the technical field of biological immunity, and particularly relates to an antibody specifically bound with IGF1R or an antigen...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
TESTING
Title Antibody specifically binding to IGF1R and application thereof
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240119&DB=EPODOC&locale=&CC=CN&NR=117417447A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dS8Mw8Jjz802nQ-cHEaRvRdOPuD1U2dLVKdiNMWVvo00zrIx2uIrMX-8lbG4vCnm6wHE5crnvC8BVfGPjNaCuiZ5OHR0Ud2w2GJWmsCORMNt2hNRVviHrvDhPQ3dYgvdlL4yeE_qlhyOiRAmU90K_19NVEMvXtZWz6zhFUH4fDDzfWHjHqJ4oSqDf8tq9rt_lBuceD42w71G0vHE5t80N2FRmtJqz335tqa6U6bpKCfZhq4fYsuIASt9vFdjly5_XKrDzvEh4V2BbV2iKGQIXUjg7hLtmVqRxnsyJ6pNUtT7RZDIncao7VEiRk8eHgPZJlCVkLUFNlK0n8_ERXAbtAe-YSNLo9_wjHq6ot6tQzvJMHgOxGjSRaKBJWzBUMVbEHOlYlmB1ykQs3BOo_Y2n9t_mKewpXqpIA22cQbn4-JTnqHuL-EIz7QdblYbl
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dT8Iw8IL4gW-KEsWvmhjeFu2-gIdpoGOCwiAEDW9k60rEkI3IjMFf77UB4UWTPl2Ty_XS631fAW7COwOvAbU09HQq6KBYY61qU6FxI-CRbRgmF6rK17ebL-bT0Bpm4H3VC6PmhH6p4YgoURzlPVXv9WwdxHJVbeX8NpwgKHnwBo5bWnrHqJ4oSqBbdxq9rttlJcYc5pf8vkPR8sZllmtbsF2W03ml6fRal10ps02V4h3ATg-xxekhZL7f8pBjq5_X8rDXWSa887CrKjT5HIFLKZwfwX0tTidhEi2I7JOUtT7BdLog4UR1qJA0Ia1Hj_ZJEEdkI0FNpK0nkvExXHuNAWtqSNLo9_wj5q-pNwqQjZNYnADRqzQSaKAJg9uoYvTANoWp69yuUJuH3DqF4t94iv9tXkGuOei0R-2W_3wG-5KvMupAq-eQTT8-xQXq4TS8VAz8AdM7idI
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Antibody+specifically+binding+to+IGF1R+and+application+thereof&rft.inventor=LIU+SHUANG&rft.inventor=WANG+TAO&rft.inventor=LIU+YANSHUANG&rft.inventor=XIE+HONGMEI&rft.inventor=LIANG+YANGQIU&rft.inventor=JI+ZHONGSHENG&rft.inventor=JIN+LEI&rft.date=2024-01-19&rft.externalDBID=A&rft.externalDocID=CN117417447A